Novartis Buys IFM Tre in Deal That Could Hit $1.6 Billion

Retrieved on: 2019-03-31 21:18:45

Tags for this article:

Proteins

Bristol-Myers Squibb

Intracellular receptors

Click the tags to see associated articles and topics

Novartis Buys IFM Tre in Deal That Could Hit $1.6 Billion. View article details on HISWAI:

Excerpt

<div>IFM Therapeutics was co-founded less than four years ago by Glick and <b>Atlas</b> <b>Venture</b>. It was seeded by an initial financing in October 2015 and ...</div>

Article found on:

View Original Article